Soft-tissue outcomes following implantation of different types of bone conduction hearing devices in a single centre.


Journal

The Journal of laryngology and otology
ISSN: 1748-5460
Titre abrégé: J Laryngol Otol
Pays: England
ID NLM: 8706896

Informations de publication

Date de publication:
Dec 2019
Historique:
pubmed: 30 11 2019
medline: 4 3 2020
entrez: 30 11 2019
Statut: ppublish

Résumé

To compare soft-tissue complications following implantation of different bone conduction hearing devices. Adults who underwent implantation of different bone conduction hearing devices, between January 2008 and December 2016, were included in the study. Five groups were identified depending on the soft-tissue approach: (1) split-thickness skin flap with use of dermatome; (2) Sheffield 'S'-shaped incision with skin thinning; (3) linear incision without skin thinning (hydroxyapatite-coated abutment); (4) 'C'-shaped full-thickness incision for passive transcutaneous bone conduction hearing devices; and (5) post-aural incision for active transcutaneous bone conduction hearing devices. The main outcome measures were different soft-tissue complications. The study comprised 120 patients (group 1 = 20 patients, group 2 = 35, group 3 = 35, group 4 = 20, and group 5 = 10). Soft tissue related problems were encountered in 55 per cent of patients from group 1, 26 per cent in group 2, 3 per cent in group 3, and 0 per cent in groups 4 and 5. There was a reduction in soft tissue related complications with reduced soft-tissue handling. In addition, there was a shift from an initial skin-penetrating (percutaneous) approach to a non-skin-penetrating (transcutaneous) approach.

Identifiants

pubmed: 31779713
doi: 10.1017/S002221511900241X
pii: S002221511900241X
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1079-1082

Auteurs

J Ray (J)

Department of Otolaryngology, Sheffield Teaching Hospitals, UK.

K Lau (K)

Department of Otolaryngology, Sheffield Teaching Hospitals, UK.

J Moraleda (J)

Department of Otolaryngology, Sheffield Teaching Hospitals, UK.

M Yardley (M)

Department of Otolaryngology, Sheffield Teaching Hospitals, UK.

M Dawoud (M)

Department of Otolaryngology, Sheffield Teaching Hospitals, UK.
Otolaryngology Department, Faculty of Medicine, Menoufia University, Al Minufya, Egypt.

P A Dimitriadis (PA)

Department of Otolaryngology, Sheffield Teaching Hospitals, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH